Senneville, E.

Autres publications scientifiques

PS28

J Antimicrob Chemother 2023, 78(12):2919-2925.

Dalbavancin plasma concentrations in 133 patients: a PK/PD observational study.

Hervochon, C. Hennart, B. Leroy, A.-G. Corvec, S. Boutoille, D. Senneville, E. Sotto, A. Illes, G. Chavanet, P. Dubée, V. Bleibtreu, A. De Carné, M.-C. Talarmin, J.-P. Revest, M. Castan, B. Bellouard, R. Dailly, E. Allorge, D. Dinh, A. Le Turnier, P. Grégoire, M.

https://doi.org/10.1093/jac/dkad331

PS27

Int J Antimicrob Agents 2023, 62(5):106960.

Expert Opinion on Dose Regimen and Therapeutic Drug Monitoring for Long-Term Use of Dalbavancin: Expert Review Panel.

Senneville, E. Cuervo, G. Grégoire, M. Hidalgo-Tenorio, C. Jehl, F. Miro, J.-M. Seaton, A. Söderquist, B. Soriano, A. Thalhammer, F. Pea, F.

https://doi.org/10.1016/j.ijantimicag.2023.106960